Dominari Inc.

NASDAQ: DOMH · Real-Time Price · USD
5.67
0.57 (11.18%)
At close: May 02, 2025, 3:59 PM
5.50
-3.00%
After-hours: May 02, 2025, 05:51 PM EDT
11.18%
Bid 5.5
Market Cap 83.03M
Revenue (ttm) 18.15M
Net Income (ttm) -14.7M
EPS (ttm) -3.86
PE Ratio (ttm) -1.47
Forward PE n/a
Analyst n/a
Ask 5.7
Volume 459,142
Avg. Volume (20D) 1,765,124
Open 5.28
Previous Close 5.10
Day's Range 5.00 - 5.71
52-Week Range 0.83 - 13.58
Beta 0.90

About DOMH

Dominari Holdings Inc., a biotechnology company, focuses on developing small-molecule anti-cancer therapeutics. The company's pipeline of therapeutics includes therapies for prostate cancer, pancreatic cancer, acute myeloid leukemia (AML), and acute lymphoblastic leukemia. It is developing DHA-dFdC, a pancreatic drug candidate; and KPC34, a small molecule treatment for acute myeloid leukemia and acute lymphoblastic leukemia. The company is also d...

Industry Biotechnology
Sector Healthcare
IPO Date Mar 18, 1980
Employees 29
Stock Exchange NASDAQ
Ticker Symbol DOMH
Full Company Profile
3 weeks ago
+9.2%
Shares of capital market companies are trading hig... Unlock content with Pro Subscription
1 month ago
-16.32%
Dominari Holdings shares are trading lower. The stock may be falling after the company announced its former wholly owned subsidiary, American Data Centers, partnered with Hut 8 to form American Bitcoin corporation.